Probability of cancer in high‐risk patients predicted by the protein‐based lung cancer biomarker panel in China: LCBP study

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|124|2|262-270

ISSN： 0008-543x

Source： CANCER, Vol.124, Iss.2, 2018-01, pp. : 262-270

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of a serum‐based biomarker panel in the early diagnosis of lung cancer for a cohort of high‐risk patients

By  

CANCER, Vol. 121, Iss. S17, 2015-09 ,pp. : 3113-3121

John Wiley & Sons Inc

Access to resources Recommend Favorite

Potentially malignant oral disorders and high‐risk habits in liver cirrhosis and lung cancer patients

By  

ORAL DISEASES, Vol. 21, Iss. 3, 2015-04 ,pp. : 373-377

John Wiley & Sons Inc

Access to resources Recommend Favorite

Increased risk of lung cancer in patients with eczema: a nationwide cohort study in Taiwan

By  

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, Vol. 14, Iss. 9, 2016-09 ,pp. : 924-931

John Wiley & Sons Inc

Access to resources Recommend Favorite

A panel of protein markers for the early detection of lung cancer with bronchial brushing specimens

By  

CANCER CYTOPATHOLOGY, Vol. 122, Iss. 11, 2014-11 ,pp. : 833-841

John Wiley & Sons Inc

Access to resources Recommend Favorite

The risk of febrile neutropenia in breast cancer patients following adjuvant chemotherapy is predicted by the time course of interleukin‐6 and C‐reactive protein by modelling

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 84, Iss. 3, 2018-03 ,pp. : 490-500

John Wiley & Sons Inc

Access to resources Recommend Favorite